Journal of Medicinal Chemistry p. 6945 - 6953 (2013)
Update date:2022-08-04
Topics:
Van Berkel, Sander S.
Brem, Jürgen
Rydzik, Anna M.
Salimraj, Ramya
Cain, Ricky
Verma, Anil
Owens, Raymond J.
Fishwick, Colin W.G.
Spencer, James
Schofield, Christopher J.
Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clinically used β-lactam antibiotics. The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate substrates and a set of clinically relevant MBLs. We report procedures for the preparation of a set of clinically relevant metallo-β-lactamases (i.e., NDM-1 (New Delhi MBL), IMP-1 (Imipenemase), SPM-1 (Sa?o Paulo MBL), and VIM-2 (Verona integron-encoded MBL)) and the identification of suitable fluorogenic substrates (umbelliferone-derived cephalosporins). The fluorogenic substrates were compared to chromogenic substrates (CENTA, nitrocefin, and imipenem), showing improved sensitivity and kinetic parameters. The efficiency of the fluorogenic substrates was exemplified by inhibitor screening, identifying 4-chloroisoquinolinols as potential pan MBL inhibitors.
View MoreJiangsu Feymer Technology Co., Ltd.
Contact:+86-512-58110622/58110118
Address:Fenghuang Town, Zhangjiagang City, Jiangsu Province, China
website:http://www.cartoonchem.com/
Contact:+86-25-58074918
Address:Room 2109, RuiHua Business Center,315 South ZhongShan Road, Nanjing 210001, China
Contact:86-511-85210668 0511-85210668, 85210818, 85210898
Address:Yihai Garden E-902,NO.99 Daxi RD., Zhenjiang Jiiangsu ,China
Laohekou huacheng Trade Co., Ltd.
Contact:+86-710-8360685
Address:No. 85, Beijing Road, Laohekou City, Hubei Province, China
Tianjin Boron PharmaTech Co.,Ltd.
Contact:86-022-59845187
Address:B9-401, Tianda Science Park,No.80,4th Avenue,TEDA,Tianjin, China
Doi:10.3762/bjoc.9.81
(2013)Doi:10.1002/chem.201204114
(2013)Doi:10.1021/acs.orglett.9b01354
(2019)Doi:10.1080/15533174.2012.754763
(2013)Doi:10.1002/anie.201206388
(2013)Doi:10.1021/ja4074563
(2013)